Impact of Neutrophil Lymphocyte and Monocyte Lymphocyte Ratio on Chronic Kidney Disease Patients Outcome - Trial NCT05887960
Access comprehensive clinical trial information for NCT05887960 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Assiut University
Timeline & Enrollment
N/A
Jun 01, 2023
Oct 01, 2024
Primary Outcome
Impact of neutrophil lymphocyte and monocyte lymphocyte ratio on chronic kidney disease patients outcome
Summary
The aim of this study is to establish NLR, MLR as a good predictors for outcome of CKD
 including hemodialysis and CKD stage (4-5) patients as regard inflammation, malnutrition and
 anemia on cardiovascular complication.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05887960
Non-Device Trial